These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1987735)
1. Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus. Engstrom PF; Ryan LM; Falkson G; Haller DG Am J Clin Oncol; 1991 Feb; 14(1):33-5. PubMed ID: 1987735 [TBL] [Abstract][Full Text] [Related]
2. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897 [TBL] [Abstract][Full Text] [Related]
3. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. Asbury RF; Blessing JA; Mortel R; Homesley HD; Malfetano J Am J Clin Oncol; 1987 Aug; 10(4):299-301. PubMed ID: 3618541 [TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group Trial. Iizuka T; Kakegawa T; Ida H; Ando N; Watanabe H; Takagi I Jpn J Clin Oncol; 1991 Jun; 21(3):176-9. PubMed ID: 1942548 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. De Besi P; Sileni VC; Salvagno L; Tremolada C; Cartei G; Fosser V; Paccagnella A; Peracchia A; Fiorentino M Cancer Treat Rep; 1986 Jul; 70(7):909-10. PubMed ID: 2424595 [TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Iizuka T; Kakegawa T; Ide H; Ando N; Watanabe H; Tanaka O; Takagi I; Isono K; Ishida K; Arimori M Jpn J Clin Oncol; 1992 Jun; 22(3):172-6. PubMed ID: 1518165 [TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction. Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg R; Benson A J Clin Oncol; 1996 Jan; 14(1):149-55. PubMed ID: 8558190 [TBL] [Abstract][Full Text] [Related]
9. Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group. Asbury RF; Kramar A; Haller DG Am J Clin Oncol; 1987 Oct; 10(5):380-2. PubMed ID: 3661489 [TBL] [Abstract][Full Text] [Related]
10. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial for the evaluation of trimetrexate in patients with inoperable squamous carcinoma of the esophagus. Falkson G; Ryan LM; Haller DG Am J Clin Oncol; 1992 Oct; 15(5):433-5. PubMed ID: 1387999 [TBL] [Abstract][Full Text] [Related]
12. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Locker GY; Kilton L; Khandekar JD; Lad TE; Knop RH; Albain K; Blough R; French S; Benson AB Invest New Drugs; 1994; 12(4):299-301. PubMed ID: 7775130 [TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy with cisplatin, 5-fluorouracil and allopurinol in the management of advanced epidermoid esophageal cancer. De Besi P; Chiarion-Sileni V; Salvagno L; Toso S; Paccagnella A; Fosser V; Tremolada C; Peracchia A; Fiorentino MV Recent Results Cancer Res; 1988; 110():196-7. PubMed ID: 3406502 [No Abstract] [Full Text] [Related]
14. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus. Wang J; Chang J; Yu H; Wu X; Wang H; Li W; Ji D; Peng W Cancer Chemother Pharmacol; 2013 Apr; 71(4):905-11. PubMed ID: 23370661 [TBL] [Abstract][Full Text] [Related]
15. A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Lovett D; Kelsen D; Eisenberger M; Houston C Cancer; 1991 Jan; 67(2):354-6. PubMed ID: 1985729 [TBL] [Abstract][Full Text] [Related]
16. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group. Asbury RF; Blessing JA; McGuire WP; Hanjani P; Mortel R Am J Clin Oncol; 1990 Feb; 13(1):39-41. PubMed ID: 2407103 [TBL] [Abstract][Full Text] [Related]
17. Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study. Lee SJ; Kim S; Kim M; Lee J; Park YH; Im YH; Park SH BMC Cancer; 2015 Oct; 15():693. PubMed ID: 26468007 [TBL] [Abstract][Full Text] [Related]
18. The value of radiotherapy or chemotherapy after intubation for advanced esophageal carcinoma--a prospective randomized trial. Schmid EU; Alberts AS; Greeff F; Terblanche AP; Schoeman L; Burger W; Shiels RA; Friediger D; Van der Hoven A; Falkson G Radiother Oncol; 1993 Jul; 28(1):27-30. PubMed ID: 7694321 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Ishida K; Iizuka T; Ando N; Ide H Jpn J Clin Oncol; 1996 Oct; 26(5):310-5. PubMed ID: 8895670 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]